Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Thomas Amatruda
Biodistribution, Shedding, and Transmissibility of the Oncolytic Virus Talimogene Laherparepvec in Patients With Melanoma
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
A Clinical Trial Investigating Biodistribution and Shedding of an Oncolytic Virus
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
479. Long Term Follow Up of Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpes Virus (Talimogene Laherparepvec, T-Vec) in Patients With Unresectable Metastatic Melanoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Potential Clinical and Immunotherapeutic Utility of Talimogene Laherparepvec for Patients With Melanoma After Disease Progression on Immune Checkpoint Inhibitors and BRAF Inhibitors
Melanoma Research
Dermatology
Cancer Research
Oncology
Talimogene Laherparepvec for Regionally Advanced Merkel Cell Carcinoma: A Report of 2 Cases
JAAD Case Reports
Dermatology
Talimogene Laherparepvec in Combination With Pembrolizumab Leads to a Complete Response in a Patient With Refractory Merkel Cell Carcinoma
JAAD Case Reports
Dermatology
642. Pre-Existing Antiviral State Can Impact Oncolytic Infection in Glioblastoma Patients Treated With Oncolytic Measles Virus
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Virus Shedding Patterns in Nasopharyngeal and Fecal Specimens of COVID-19 Patients
Comparison of Respiratory Virus Shedding by Conventional and Molecular Testing Methods in Patients With Haematological Malignancy
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Correction To: The Role of Oncolytic Viruses in the Treatment of Melanoma
Current Oncology Reports
Oncology
